Dusk Group (ASX:DSK) isn’t smelling so good after its 1HY23 results
Dusk Group (ASX:DSK) is the latest company that saw a sales growth amidst the pandemic to report a ‘return to normal’ in its 1HY23 result. This company provides home fragrance products including candles, diffusers and essential oils, both online and at its network of ~140 stores.
No time to do stock research, but you still want to invest?
Stocks Down Under Concierge gives you timely BUY and SELL alerts on ASX-listed stocks!
With price targets, buy ranges, stop loss levels and Sell alerts too.
GET A 3-MONTH FREE TRIAL TO CONCIERGE TODAY
DSK has some good metrics, but sales and earnings are down
Turning to the figures that matter most, although DSK’s total sales grew 7.6%, this figure was only higher due to lockdowns that closed a number of stores in the prior corresponding period.
Like for like sales, which means total sales excluding stores closed because of COVID, fell by 10.4%. Online like for like sales fell by 37.8%, reflecting the return of consumers to brick and mortar stores. The company’s NPAT was $13.3, which was 9.5% lower and represents a 15.5% margin (down from 18.4%).
There were some metrics that appeared positive, however. One was the continue growth in its reward program from 718,000 to 722,000. These members accounted for 59% of total sales and had a higher average transaction value compared to non-members.
Most pleasingly for investors, DSK paid an interim dividend of 8c per share which was an 8.5% yield on an annualised yield.
An uncertain outlook
DSK also reported that total sales for the first 7 weeks of 2HY23 were 3% lower compared to the prior corresponding period and it declined to give FY23 earnings guidance.
The company is looking for a new CEO, to replace Peter King, and it will open 6 further stores in the coming months.
Stocks Down Under Concierge gives you timely BUY and SELL alerts on ASX-listed stocks!
With price targets, buy ranges, stop loss levels and Sell alerts too.
GET A 3-MONTH FREE TRIAL TO CONCIERGE TODAY
No credit card needed and the trial expires automatically.
Blog Categories
Get the Latest Insider Trades on ASX!
Recent Posts
AMA Group (ASX:AMA) recovery is now being tested by whether cash flow can sustain the turnaround
AMA Group (ASX: AMA)’s recovery story is now being tested by whether improving earnings can translate into durable cash flow…
Radiopharm Theranostics (ASX: RAD) is increasingly defined by whether RAD101 can justify a registrational pathway
Radiopharm Theranostics (ASX:RAD) is increasingly defined by whether its lead imaging asset RAD101 can convert encouraging mid-stage data into a…
3P Learning (ASX:3PL) must arrest school churn to protect its valuation
3P Learning (ASX: 3PL)’s valuation now hinges on whether the business review can arrest B2B school churn and declining revenue…